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Aldosterone Modulates the 
Association between NCC and 
ENaC
Brandi M. Wynne  1,4, Abinash C. Mistry1, Otor Al-Khalili2, Rickta Mallick1, Franziska Theilig3, 
Douglas C. Eaton2,4 & Robert S. Hoover1,2,5
Distal sodium transport is a final step in the regulation of blood pressure. As such, understanding how 
the two main sodium transport proteins, the thiazide-sensitive sodium chloride cotransporter (NCC) 
and the epithelial sodium channel (ENaC), are regulated is paramount. Both are expressed in the late 
distal nephron; however, no evidence has suggested that these two sodium transport proteins interact. 
Recently, we established that these two sodium transport proteins functionally interact in the second 
part of the distal nephron (DCT2). Given their co-localization within the DCT2, we hypothesized that 
NCC and ENaC interactions might be modulated by aldosterone (Aldo). Aldo treatment increased NCC 
and αENaC colocalization (electron microscopy) and interaction (coimmunoprecipitation). Finally, 
with co-expression of the Aldo-induced protein serum- and glucocorticoid-inducible kinase 1 (SGK1), 
NCC and αENaC interactions were increased. These data demonstrate that Aldo promotes increased 
interaction of NCC and ENaC, within the DCT2 revealing a novel method of regulation for distal sodium 
reabsorption.
Hypertension is a primary cause of death and disability in the United States and worldwide1. Understanding 
the mechanisms that cause hypertension is crucial in combatting this debilitating disease. Increased renal 
sodium (Na+) reabsorption is a primary pathogenic factor. Although the vast majority of Na+ is reabsorbed 
within the proximal tubule, the aldosterone-sensitive distal nephron (ASDN) is where fine-tuning and regulation 
of Na+ handling occurs. The ASDN expresses two primary sodium transport proteins- the thiazide-sensitive 
sodium-chloride cotransporter (NCC) and the epithelial sodium channel (ENaC). Genetic aberrations in either 
lead to a disruption in sodium homeostasis and either hyper- or hypotension. Indeed, all currently known inher-
ited and acquired forms of hypertension affect renal sodium (Na+) chloride (NaCl) handling, with most involving 
these two transport proteins2–4.
The ASDN is comprised of the late distal convoluted tubule (DCT2), connecting tubule (CNT) and corti-
cal collecting duct (CCD). NCC is expressed fully along the DCT, while ENaC expression begins at the DCT2 
and continues throughout the remainder of the ASDN. Studies have demonstrated that NCC and ENaC are 
co-expressed in one segment of the ASDN, the DCT25–12. However, no studies have suggested any interaction 
between these two transport proteins. Indeed, anatomical and/or functional interactions between channels and 
transporters are rare. However, our laboratory has recently demonstrated that NCC and ENaC physically associ-
ate in vivo and in vitro using both co-immunoprecipitation (CoIP) and electron microscopy (EM) immunogold 
labeling. Utilizing a mammalian two-hybrid system we then demonstrated a direct interaction between these 
proteins12. Additionally, inhibition of NCC function with thiazides reduced ENaC open probability, confirm-
ing a functional interaction of these proteins12. However, mechanisms that might regulate this interaction are 
unknown. Given their location in the ASDN, we hypothesized that aldosterone might modulate their interac-
tions. Here we report that this hypothesis is true; the interaction of these two key Na+ transport proteins is regu-
lated by aldosterone.
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Results
EM demonstrates increased NCC and ENaC interaction after aldosterone stimulation. Given 
the importance of Aldo in regulating both NCC and ENaC, we hypothesized that Aldo would modulate their 
interactions in the DCT2. Therefore we treated mice on a high salt diet (4%) with Aldo or vehicle for 10 days 
and EM immunogold labeling was performed12. High salt diet was used to suppress systemic renin-angiotensin 
II- aldosterone (RAAS) levels. Apical images were obtained from the DCT2, the only portion of the nephron 
containing both NCC and ENaC. As demonstrated previously, under control conditions NCC and γENaC (NCC, 
12 nm; γENaC, 6 nm) were occasionally found in close proximity on the apical surface of the DCT (Fig. 1A,B; 
inset). When mice were treated with Aldo, we observed an approximate 3 fold increase in NCC and ENaC colo-
calization (0.03 mean occurrences control vs. 0.08 mean occurrences in Aldo-treated) (Fig. 1C,D; inset and E–J). 
These qualitative data suggest that hormonal stimulation modulates NCC and ENaC interactions.
Aldosterone treatment increases NCC-ENaC coimmunoprecipitation in vitro and in 
vivo. Having shown that physiological levels of Aldo treatment increased interaction of NCC and ENaC using 
EM we examined whether Aldo alters their interaction by CoIP in vivo and in vitro. In Fig. 2, CoIP experi-
ments were performed with whole cell lysates from mDCT15 cells treated with Aldo (100 nm, 48 hrs) or vehicle 
(EtOH). Previously, we have confirmed the specificity of our protocol and showed that Na/K-ATPase (α sub-
unit) and GAPDH do not immunoprecipitate with NCC12. When comparing the fold changes in αENaC pro-
tein expression with Aldo treatment in total lysate, no significant changes were observed compared to vehicle 
treatment (0.98 ± 0.12 fold change/vehicle, n = 4) (Fig. 2a,d). A slight, yet insignificant decrease was found with 
Aldo + SGK1-inhibitor (0.71 ± 0.15 fold change/vehicle, n = 3) However, as shown in Fig. 2b and d, Aldo stim-
ulation resulted in increased αENaC immunoprecipitation with NCC (2.05 ± 0.43 fold change/vehicle, p < 0.05, 
n = 4–5). Similarly, NCC total protein expression was unchanged with Aldo treatment (0.99 ± 0.04 fold change/
vehicle, n = 3–4) or co-treatment with Aldo and the SGK1 inhibitor (0.97 ± 0.04 fold change/vehicle, n = 3–4). 
When we compared the αENaC and NCC present in the CoIP fractions, we observed an approximate 1.5 fold 
increase in αENaC present (1.55 ± 0.20 fold change/vehicle, n = 3). This suggests that the increased interactions 
observed between NCC and αENaC are not a simple function of increased total protein expression.
To examine the Aldo-dependent increases in NCC-αENaC interactions, we used an SGK1 inihbitor 
(GSK690394, 6 uM, 60 min). Following Aldo + SGK1 inhibition, we observed a trend for reduced NCC-αENaC 
interaction (2.05 ± 0.43 Aldo vs. 1.55 ± 0.41, Aldo + SGK1 inhibitor, Fig. 2). For all experiments, no signifcant 
changes were observed in GAPDH expression, nor were interactions observed with Co-IP resin only (no anti-
body, representative blot shown Fig. 2e). These data suggest a quantitative increase in NCC-αENaC interaction 
with Aldo stimulation. With SGK1 inhibition, there is a trend for a reduced interaction.
Although the mDCT15 cell line is the best available DCT2 culture model, we also explored this phenomenon 
in vivo. Mice were treated with Aldo via mini-osmotic pump (4 ug/day, 10 d) or vehicle (25% DMSO in saline) 
and were fed high salt chow (4%) to reduce systemic Aldo and AngII production. Following Aldo treatment, 
whole cortex homogenates were used for CoIP studies12. NCC and αENaC protein interactions were increased 
with Aldo treatment (3.07 ± 0.79 fold change/vehicle, *p < 0.05, n = 6, Fig. 3a,c). Furthermore, this increased 
interaction was not accompanied by an appreciable increase in αENaC expression in total cortex lysate (Fig. 3b,c). 
When looking at NCC expression in whole cortex homogenates, there was a trend for increased NCC total pro-
tein amounts, yet no significant increases were observed (Fig. 3d). These data confirm that the increased inter-
actions observed between NCC and αENaC with Aldo treatment are not a function of increased total protein 
expression.
NCC and αENaC subunit interactions are modulated via aldosterone-sensitive pathways. We 
have demonstrated that NCC and αENaC increase their biochemical interactions following Aldo treatment. 
To investigate whether the direct binding of NCC and ENaC was also regulated by aldosterone signaling path-
ways, we performed mammalian 2-hybrid assays using transiently transfected COS-7 cells, and a dual-luciferase 
reporter assay. In addition to baseline NCC-α, γ ENaC interactions, we assessed whether SGK1 and WNK4 
affected their binding. COS-7 cells were transiently transfected with either: empty vectors (pBIND, pACT), pos-
itive (Myo-pACT + Id-pBIND) and/or NCC-pBIND, αENaC or γ-pACT, SGK1 or WNK4. This model of SGK1 
overexpression was used to simulate increased Aldo-mediated MR activity since COS-7 cells have limited func-
tional expression and/or activity of the MR.
We observed a similar baseline interaction (Fig. 4a) between NCC and αENaC (7.74 ± 0.77 vs. negative, 
n = 7–12, ***p < 0.0001). With the additional transfection of the SGK1 vector, we saw a further increase in direct 
NCC-αENaC interaction with observed values (14.68 ± 1.58 vs. NCC-αENaC alone, n = 7–12, *p < 0.05) reach-
ing values similar to positive control-transfected groups, supporting our previous data obtained using a different 
mammalian 2-hybrid system/reporter, and now confirming that Aldo-sensitive pathways increase NCC/ENaC 
interactions. When cells were co-transfected with WNK4, as a control for other proteins that regulate NCC, no 
increase in interaction was observed. This demonstrates the specificity of the SGK1-Aldo mediated pathways.
To investigate whether this process occurs with the γ subunit, similar experiments were performed. As 
shown in Fig. 4b, NCC and γENaC exhibit a consistent baseline interaction (4.33 ± 0.67 vs. negative, n = 8–12, 
**p < 0.01). In contrast, co-expression of either SGK1 or WNK4 produced no changes in NCC-γENaC 
interaction.
Discussion
NCC and ENaC have similar regulatory pathways, frequently exhibiting converging mechanisms of regulation 
and their roles in maintaining Na+ balance cannot be understated. The overlap of NCC and ENaC expression 
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occurs only along the second portion of the DCT, or DCT2. Understanding the regulation of these two transport 
proteins within the distal nephron is crucial in developing paradigms for distal electrolyte transport.
Both NCC and ENaC are regulated by the primary sodium conservation hormone Aldo, which is synthesized 
in the zona glomerulosa of the adrenal cortex and is an essential part of the RAAS system13. During times of 
Figure 1. Electron microscopy detects close proximity of NCC and ENaC in murine kidney cortex after 
aldosterone treatment. Immunogold labeling of NCC (12 nm particles) and γENaC (6 nm particles) in mouse 
DCT2 of (A,B) vehicle (25% DMSO in saline) and (C–J) Aldo-treated kidney cortex. The inserts (A–D) show 
a magnified view of closely associated NCC and γENaC. Figures E–J are magnified views of increased NCC- 
γENaC intracellular colocalization, close to the cell surface (E–G) and in intracellular vesicles (H–J). Scale 
bar = 1 μm.
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hypovolemia, feedback mechanisms stimulate the production of angiotensin II (AngII) and Aldo. With a reduc-
tion in volume, increased Aldo production occurs, leading to activation of several important pathways. Given this 
regulation of both NCC and ENaC by Aldo, we hypothesized that Aldo would also modulate their interaction. 
To investigate this, we first determined if Aldo stimulation would lead to increased NCC-ENaC proximity for 
interaction (colocalization) in the DCT2 of murine cortex using EM (Fig. 1). We found a qualitative increase in 
colocalization with Aldo treatment, as compared to kidneys from vehicle-treated mice.
Recently, investigators have shown that the regulation of NCC by Aldo may occur only in DCT2. This is largely 
due to the presence of 11β-HSD2. This enzyme converts cortisol to inactive cortisone, conferring ‘Aldo-sensitivity’ 
to a particular cell14. Studies have shown that 11β-HSD2 is not expressed in the DCT1; however, Poulsen and col-
leagues demonstrate that 11β-HSD2 is clearly expressed in the DCT2, but show that the expression levels were 
not as high as the CNT or the CCD15, 16. It should be noted that the 11β-HSD2 expression level, under high Aldo 
conditions, is currently unknown in the DCT2. Together, these data suggest that Aldo-sensitivity may exist in 
the DCT2 where both NCC and ENaC are localized. In addition, this preferential Aldo effect of the DCT2 could 
also be because of non-genomic Aldo effects, or secondary to potassium (K+) concentrations. However, the rea-
sons why K+ levels would affect the DCT2 vs. the DCT1 (where 11β-HSD2 is clearly not expressed) are unclear. 
Regardless of the mechanism, there is a clear differential affect of DCT1 vs. DCT2.
Others have suggested that DCT2/CNT localized ENaC is largely insensitive to Aldo; however in that man-
uscript, those authors were unable to completely distinguish between the DCT2 and CNT17. We think this is an 
important distinction, as we have previously demonstrated that ENaC properties are altered in the presence of 
NCC (HCTZ reduced ENaC PO)12, as would be the case in the DCT2 and not CNT. Thus, while ENaC regula-
tion in the CNT appears insensitive to Aldo, we believe this effect has not been fully examined in DCT2. Here, 
we reveal an Aldo-dependent regulation of NCC and ENaC interaction within the DCT2. Therefore one such 
interpretation of these data are that increased NCC may lead to increased ENaC activity in a portion of the distal 
nephron where ENaC is not classically Aldo-sensitive.
To quantitatively determine if this increased interaction is independent of increased protein expression, we 
performed CoIP studies using mDCT15 cells, which natively express DCT2 signaling pathways and kidney cortex 
from sham and Aldo-treated mice. Aldo treatment significantly increased NCC and αENaC interaction in both 
mDCT15 cells as well as murine kidney cortex (Figs 2 and 3). Surprisingly, in our model using Aldo-treated mice 
fed a HS (4%) diet, no increase in αENaC expression (Fig. 3b–d) was observed in whole cortex homogenates. 
Figure 2. Coimmunoprecipitation demonstrated increased association of NCC and αENaC in mouse distal 
convoluted cells with Aldo stimulation. Total cell lysate of mDCT15 cells were immunoprecipitated (IP) with 
anti-NCC antibody and probed with αENaC antibodies in vehicle, Aldo-treated (100 nM, 48 hrs), Aldo + SGK1 
inhibitor (GSK690394, 6 uM, 60 min) or with SGK1 inhibitor alone. (a) mDCT15 total lysate probed with 
αENaC. (b) mDCT15 cell lysate IP with NCC and probed with αENaC antibody (c) mDCT15 cell lysates 
probed with NCC following respective treatments (d) Representative blots for CoIP experiments. Blots were 
cut to assay for multiple antibodies. (e) No antibody lanes contain lysate with resin only. Separation in images 
shown with a space. Data represented as mean ± SEM, n = 5; Wilcoxin Signed-Rank, *p < 0.05.
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Figure 3. Coimmunoprecipitation demonstrated increased association of NCC and αENaC aldosterone-
treated mice. (a) Mouse kidney cortex homogenates were used and CoIP performed; CoIP fraction probed 
with αENaC antibodies in vehicle (25% DMSO in saline) or Aldo-treated (4 μg) mice for 10 days, fed high salt 
(4%) chow. (b) Whole kidney cortex lysate probed with αENaC. (c) Representative blots for CoIP experiments. 
Blots were cut to assay for multiple antibodies. (d) Whole kidney cortex homogenate probed with NCC and (e) 
representative blots for NCC (lysate and and CoIP fraction) and loading control (GAPDH). Blots were cut to 
assay for multiple antibodies. Separation in images shown with a space. Data represented as mean ± SEM, n = 6; 
Wilcoxin Signed-Rank, *p < 0.05.
Figure 4. Mammalian two-hybrid demonstrates direct SGK1-mediated NCC and ENaC interaction. 
Mammalian two-hybrid assay performed on transiently transfected COS-7 cells with: empty vectors (pBIND, 
pACT), positive (Myo-pAct + Id-pBIND) and/or NCC-pBIND, αENaC (4A) or γ-pAct (4B), SGK1 or WNK4. 
Empty vector pCDNA was used to normalize for total amounts of DNA transfected. COS-7 cells lysed and 
values of Firefly and Renilla luciferase obtained. Firefly luciferase data were normalized to Renilla and all 
data expressed as fold change of negative control group (empty vector pBIND + pAct). Data represented as 
mean ± SEM, n = 7–12, at least 3 separate experiments: (a) ANOVA, *p < 0.05, **p < 0.01, ***p < 0.0001, (b) 
Kruskal-Wallis, **p < 0.01, ****p < 0.0001.
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However, similar results were observed with adrenalectomized rats infused with Aldo (200 ug/day + HS, 4 days). 
In those studies, Wang and colleagues also found that αENaC protein expression was not increased18. Other 
investigators have also shown that Aldo treatment increases DCT2 NCC protein expression levels to that of the 
DCT115. Here, our data also suggest that Aldo can increase NCC-αENaC interaction.
Aldo mediates intracellular signaling via activation of the intracellular mineralocorticoid receptor (MR)- a 
member of the nuclear receptor superfamily19, 20. Activation of the MR produces dimerization and nuclear trans-
location where it participates in the activation of a variety of genes which regulate the increase in Na+/K+ ATPase, 
ENaC and ROMK channels, including SGK121. SGK1 is expressed ubiquitously, and is regulated by a variety 
of factors increasing Na+ reabsorption22, 23. Some studies have suggested that SGK1 can directly phosphorylate 
ENaC subunits, although this has not been conclusively determined24. However, it is known that SGK1 potently 
stimulates increased ENaC at the apical membrane, and possibly increases open probability (PO). ENaC transcrip-
tion is likewise increased with SGK1 activation25, 26. Most importantly, ubiquitinylation by NEDD4–2 leads to 
internalization and degradation of ENaC and NCC via proteosomal degradation. Active SGK1 phosphorylation 
of NEDD4–2 reduces Nedd4–2 activity, thereby increasing NCC and ENaC membrane abundance23, 27. In our in 
vitro model, we used pharmacological inhibition of SGK1 before performing CoIP experiments. Interestingly, 
SGK inhibition exhibited a trend for reducing this interaction in vitro, although not significantly. However, in 
Fig. 4a, we co-transfected NCC and αENaC with SGK1 and performed M2H experiments. The expression of 
SGK1 dramatically increased direct NCC and αENaC interactions. We can only speculate that our in vivo exper-
iments with Aldo + HS treatment increased SGK1 levels; if so, the M2H data support our CoIP findings where 
SGK1 inhibition showed a trend for reducing their interaction and in vivo where Aldo + HS increased interac-
tions. The differences observed between the in vitro CoIP and M2H experiments may indicate the complicated 
regulation of the SGK1 pathway; however, strong SGK1 stimulation leads to increase NCC-αENaC interactions.
In order to determine if αENaC is the predominant binding partner, similar experiments were performed with 
NCC and γENaC (Fig. 4b). Surprisingly, only interactions were seen at baseline. There was no augmentation with 
SGK1 overexpression. These results suggest that increased interactions via Aldo may be mediated through the α 
subunit or that Aldo affects the binding of γENaC through a non-SGK1-mediated mechanism. Overall, these data 
show that Aldo increases NCC-ENaC interactions and reveal new mechanistic insight into distal Na+ handling. 
Given our new understanding of the molecular interactions that exist between NCC and ENaC, determining how 
they might be co-regulated is paramount.
Our laboratory has demonstrated that these two transport proteins not only exist in a macromolecular com-
plex, but consistently interact12. Additionally, this novel and previously unsuspected occurence has raised other 
multiple important questions which need to be further investigated. In summary, we have explored the hypothesis 
that the NCC-αENaC interaction can be dynamically modulated via Aldo, and that this interaction is not static. 
We speculate that this study may reveal a reason why thiazide diuretics are so efficacious in hypertensive patients; 
thiazides are inhibiting the increased Aldo-mediated activation of NCC with ENaC in the DCT2. Previously we 
have shown that using a thiazide diuretic inhibits the activity of both NCC and ENaC, when they are associated. 
And here, we demonstrate that during conditions of increased Aldo, this interaction is increased. It is potentially 
during these circumstances, where there is increased ENaC interaction with NCC, thiazides would have a greater 
ability to inhibit both NCC and ENaC in the DCT2.
Materials and Methods
Materials. Chemicals were purchased from Sigma-Aldrich (St. Louis, MO), unless stated otherwise.
Cell Culture and Treatments. mDCT15 cells were plated on cell culture dishes and grown in medium containing 
a 50:50 mix of DMEM/F12 plus 5% heat-inactivated fetal bovine serum (FBS) and 1% penicillin/streptomycin/
neomycin (P/S/N), at 37 °C. Experiments were conducted when the cells reached 90–95% confluence.
Standard Immunoblotting. mDCT15 cells were incubated as above. The cells were harvested, lysed using buffer 
containing protease inhibitor, and homogenized by sonication on ice. The cell lysates were centrifuged briefly 
and supernatant was collected. Proteins were transferred electrophoretically to PVDF membranes. After block-
ing with 3% BSA, the membranes were probed with corresponding primary antibodies; anti-NCC28 1:4000–
1:8000, Actin (Cell Signaling, 1:1000) overnight at 4 °C. All ENaC antibodies (1:200–1:1000 dilution) utilized 
for immunoblotting were from the laboratory of Dr. Douglas Eaton and have been validated29–31. The NCC anti-
body (1:4000–1:8000) was developed and validated in the laboratory of Robert Hoover28. The blots were washed 
in TBST (tris-buffered saline, tween 0.5%) and secondary antibodies were HRP-linked (Amersham, 1:5000). 
Supersignal West Pico was used for chemiluminescence (Thermo Scientific). Chemiluminescence was detected 
with G:Box (Gelbox) and analysis by Genetools software (Syngene, Frederick MD).
Animal Preparation and Experimentation. The Emory University Institutional Animal Care and Use Committee 
(IACUC) approved all animal protocols; experiments, methods and aseptic surgeries were performed accord-
ing to those guidelines set by IACUC and all animal welfare regulations. Mice were kept in cages with auto-
claved bedding and received free access to water and a standard diet (Diet 5001; Purina, 0.4% Na) or high salt 
diet (4%, Teklad Harland Laboratories, Indianapolis IN). Mice were implanted with miniosmotic pumps (Alzet, 
CA) containing aldosterone (4 μg/day, 25% DMSO, 10days, n = 6 mice/group). Sham mice were implanted with 
miniosmotic pumps containing vehicle solution; both groups were supplemented with high salt (4%) chow to 
reduce systemic Aldo production. Mice were euthanized using carbon dioxide, approved through Emory IACUC 
(IACUC protocol #DAR-2002607-012417BN). Kidneys were then harvested and the cortex dissected.
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Electron Microscopy. Electron microscopy (EM) studies were performed using perfused kidneys from vehicle 
and Aldo-infused mice, all fed high salt (4%) chow. Kidneys were fixed by in vivo perfusion of 3% PFA/PBS, fol-
lowed by post-fixation of kidney slices with 3%PFA/0.1% glutaraldehyde/PBS for 2 hours and cryoembedding. 
Ultrathin sections were blocked with serum-free protein block (Dako) followed by double staining with guinea 
pig anti-NCC antibody and rabbit anti-γENaC antibody (gifts of Johannes Loffing)32. Secondary antibodies were 
colloidal gold labeled anti-guinea pig (12 nm) and anti-rabbit (6 nm) both from Jackson laboratories. Images were 
captured with a Phillips CM-100 TEM.
To analyze approximate increases in NCC- γENaC colocaliztion, the DCT2 was identified from the location 
within the renal cortex via morphological appearance of the epithelium, and the coexistence of NCC and γENaC 
labeling. Using the open source software Image J (NIH), images of immunogold labeling of NCC (12 nm gold 
particles) and γENaC (6 nm gold particles) were quantified by the occurrence of NCC or ENaC particles at the 
plasma membrane and expressed as gold particles per plasma membrane length, and by the occurrence of NCC 
or γENaC particles intracellularly expressed as gold particles per cell area. This was performed in both control (15 
sections counted) and Aldo-treated (27 sections counted) kidneys. The proximity of both proteins close enough 
for interaction (colocalization) was defined as distance between NCC and γENaC-gold particles <40 nm and 
expressed as occurrence per cell area. A distance of <40 nm was used, because of the biochemical approach using 
the linker technology where proximity of 2 proteins <40 nm is necessary to hybridize their primary antibodies 
used for detection, as desribed previously33.
Co-immunoprecipitation (CoIP). mDCT15 cells or mouse kidney cortex (n = 6 mice/group) was lysed and BCA 
protein quantification performed. Total amounts of protein lysate (cells or whole cortex homogenates) used for 
the CoIP experiment were exactly the same for each sample (≈800 μg/experimental group per column) in the 
experiment. The resin beads were coupled to NCC, and then the samples were immunoprecipitated using all 
included buffers and reagents, according to the manufacturer’s instructions (Pierce Co-Immunoprecipitation 
Kit). Following, the total lysate/cell homogenates and corresponding eluted CoIP fractions were electrophoresed 
in equal quantities for each experiment (20 μg protein for each cell lysate and 20 μL for each CoIP fraction) and 
immobilized to PVDF membrane for immunoblotting with αENaCα, NCC or GAPDH. Antibodies for immu-
noprecipitation were the same as used for immunoblotting.
Preparation of Kidney Cortex. Mouse kidney cortex was homogenized in a glass tissue grinder in ice-cold RIPA 
buffer (1× protease inhibitors cocktail & 1× phosphatase inhibitor, ThermoScientific, Waltham, MA). After 
centrifugation (13,000 rpm, 20 min, 4 °C) protein concentrations were determined using BCA Protein Assay 
kit (ThermoScientific). The appropriate amount of each sample was diluted in a Tris-glycine/SDS sample buffer 
(125 mM Tris, pH 6.8, 4% SDS, 10% glycerol, 3% β-mercaptoethanol, 0.02% bromophenol blue) and heated at 
70 °C for 15 min prior to loading for SDS-PAGE.
Mammalian Two-hybrid Assay. We utilized the Checkmate Mammalian Two-hybrid (M2H) assay kit (Clontech, 
Madison WI). A full-length clone for NCC was inserted into the DNA-binding domain (pBIND) plasmid vector, 
pBIND, to form a fusion protein with DNA-binding domain, GAL4 (NCC-pBIND). The pBIND vector also con-
tains Renilla reniformis luciferase under the control of the SV40 promoter, to control for transfection efficiency. 
The pACT vector contains the herpes simplex virus VP16 activation domain upstream of a multiple cloning 
region, where full-length clones of each subunit of ENaC (α-, β- or γ-pACT) were inserted. Both vectors were 
sequenced to confirm sequence alignment before experimentation (GeneWiz, South Plainfield, NJ). Empty vec-
tors (pBIND/pACT), not containing ENaC subunits, were used in negative control experiments. COS-7 cells 
were transiently transfected with these vectors, along with the pG5luc vector, which contains five GAL4 binding 
sites upstream of a minimal TATA box upstream of the firefly luciferase gene (luc+). In addition, cells were 
co-transfected with either With no-lysine kinase 4 (WNK4) or serum- and glucocorticoid-inducible kinase 1 
(SGK1) overexpression vectors. To ensure total transfected DNA amounts were the same in each experiment, 
pCDNA was used to equalize transfected quantity. Positive control vectors containing myo and id (Myo-pACT, 
Id-pBIND) which are two proteins known to highly interact, were supplied by Clontech and used to control for 
assay. 48 hours after transfection cells were lysed and binding was assessed by measuring reporter gene expres-
sion (firefly luciferase) via Dual-Luciferase Reporter Assay System (Clontech, Madison WI), per manufacterer’s 
instructions.
Statistical Analysis. Western blot data from CoIP experiments were quantified and expressed as fold change 
over the vehicle-treated group. Statistical analysis was performed using the GraphPad software package (La Jolla, 
CA). Error bars represent SEM. Data were analyzed for statistical significance using a paired t-test, ANOVA (with 
Tukey’s posthoc analysis), Wilcoxin-Signed Rank or Mann-Whitney Rank Sum/Kruskal-Wallis (with Dunn’s 
posthoc analysis), where appropriate. A p-value of less than 0.05 was considered statistically significant.
References
 1. Chobanian, A. V. et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of 
High Blood Pressure: The JNC 7 Report. JAMA 289, 2560–2571, doi:10.1001/jama.289.19.2560 (2003).
 2. Simon, D. B. et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-
sensitive Na-Cl cotransporter. Nat Genet 12, 24–30 (1996).
 3. Lifton, R. P., Gharavi, A. G. & Geller, D. S. Molecular mechanisms of human hypertension. Cell 104, 545–556 (2001).
 4. Eladari, D., Chambrey, R., Picard, N. & Hadchouel, J. Electroneutral absorption of NaCl by the aldosterone-sensitive distal nephron: 
implication for normal electrolytes homeostasis and blood pressure regulation. Cell Mol Life Sci 71, 2879–2895, doi:10.1007/s00018-
014-1585-4 (2014).
www.nature.com/scientificreports/
8Scientific RepoRts | 7: 4149  | DOI:10.1038/s41598-017-03510-5
 5. Biner, H. L. et al. Human Cortical Distal Nephron: Distribution of Electrolyte and Water Transport Pathways. J Am Soc Nephrol 13, 
836–847 (2002).
 6. Loffing, J. et al. Distribution of transcellular calcium and sodium transport pathways along mouse distal nephron. Am J Physiol Renal 
Physiol 281, F1021–1027 (2001).
 7. Loffing, J. & Kaissling, B. Sodium and calcium transport pathways along the mammalian distal nephron: from rabbit to human. Am 
J Physiol Renal Physiol 284, F628–643 (2003).
 8. Schmitt, R. et al. Developmental expression of sodium entry pathways in rat nephron. American Journal of Physiology - Renal 
Physiology 276, F367–F381 (1999).
 9. Obermuller, N. et al. Expression of the thiazide-sensitive Na-Cl cotransporter in rat and human kidney. Am J Physiol 269, F900–910 
(1995).
 10. Loffing, J. et al. Differential subcellular localization of ENaC subunits in mouse kidney in response to high- and low-Na diets. 
American Journal of Physiology - Renal Physiology 279, F252–F258 (2000).
 11. Christensen, B. M. et al. Sodium and Potassium Balance Depends on αENaC Expression in Connecting Tubule. Journal of the 
American Society of Nephrology 21, 1942–1951, doi:10.1681/asn.2009101077 (2010).
 12. Mistry, A. C. et al. The Sodium Chloride Cotransporter (NCC) and Epithelial Sodium Channel (ENaC) Associate. Biochem J 473, 
3237–3252, doi:10.1042/BCJ20160312 (2016).
 13. Root, A. W. Disorders of aldosterone synthesis, secretion, and cellular function. Curr Opin Pediatr 26, 480–486, doi:10.1097/
MOP.0000000000000104 (2014).
 14. Bostanjoglo, M. et al. 11Beta-hydroxysteroid dehydrogenase, mineralocorticoid receptor, and thiazide-sensitive Na-Cl cotransporter 
expression by distal tubules. J Am Soc Nephrol 9, 1347–1358 (1998).
 15. Poulsen, S. B. & Christensen, B. M. Long-term aldosterone administration increases renal Na+ -Cl- cotransporter abundance in late 
distal convoluted tubule. Am J Physiol Renal Physiol ajprenal 00352 02016, doi:10.1152/ajprenal.00352.2016 (2016).
 16. Ackermann, D. et al. In vivo nuclear translocation of mineralocorticoid and glucocorticoid receptors in rat kidney: differential effect 
of corticosteroids along the distal tubule. American Journal of Physiology - Renal Physiology 299, F1473–F1485, doi:10.1152/
ajprenal.00437.2010 (2010).
 17. Nesterov, V. et al. Aldosterone-dependent and -independent regulation of the epithelial sodium channel (ENaC) in mouse distal 
nephron. Am J Physiol Renal Physiol 303, F1289–1299, doi:10.1152/ajprenal.00247.2012 (2012).
 18. Wang, X. Y. et al. The renal thiazide-sensitive Na-Cl cotransporter as mediator of the aldosterone-escape phenomenon. J Clin Invest 
108, 215–222, doi:10.1172/JCI10366 (2001).
 19. Ferrario, C. M. & Schiffrin, E. L. Role of mineralocorticoid receptor antagonists in cardiovascular disease. Circ Res 116, 206–213, 
doi:10.1161/CIRCRESAHA.116.302706 (2015).
 20. Rautureau, Y., Paradis, P. & Schiffrin, E. L. Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle 
cells. Steroids 76, 834–839, doi:10.1016/j.steroids.2011.02.015 (2011).
 21. Viengchareun, S. et al. The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology. Nucl Recept 
Signal 5, e012, doi:10.1621/nrs.05012 (2007).
 22. Lang, F., Artunc, F. & Vallon, V. The physiological impact of the serum and glucocorticoid-inducible kinase SGK1. Curr Opin 
Nephrol Hypertens 18, 439–448, doi:10.1097/MNH.0b013e32832f125e (2009).
 23. Lang, F. et al. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev 86, 
1151–1178, doi:10.1152/physrev.00050.2005 (2006).
 24. Diakov, A. & Korbmacher, C. A novel pathway of epithelial sodium channel activation involves a serum- and glucocorticoid-
inducible kinase consensus motif in the C terminus of the channel’s alpha-subunit. J Biol Chem 279, 38134–38142, doi:10.1074/jbc.
M403260200 (2004).
 25. Kamynina, E. & Staub, O. Concerted action of ENaC, Nedd4-2, and Sgk1 in transepithelial Na(+) transport. Am J Physiol Renal 
Physiol 283, F377–387, doi:10.1152/ajprenal.00143.2002 (2002).
 26. Alvarez de la Rosa, D., Zhang, P., Naray-Fejes-Toth, A., Fejes-Toth, G. & Canessa, C. M. The serum and glucocorticoid kinase sgk 
increases the abundance of epithelial sodium channels in the plasma membrane of Xenopus oocytes. J Biol Chem 274, 37834–37839 
(1999).
 27. Arroyo, J. P. et al. Nedd4-2 Modulates Renal Na+-Cl- Cotransporter via the Aldosterone-SGK1-Nedd4-2 Pathway. Journal of the 
American Society of Nephrology 22, 1707–1719, doi:10.1681/asn.2011020132 (2011).
 28. Ko, B. et al. A new model of the distal convoluted tubule. American Journal of Physiology - Renal Physiology 303, F700–F710, 
doi:10.1152/ajprenal.00139.2012 (2012).
 29. Greenlee, M. M. et al. Estradiol activates epithelial sodium channels in rat alveolar cells through the G protein-coupled estrogen 
receptor. American Journal of Physiology - Lung Cellular and Molecular Physiology 305, L878–L889, doi:10.1152/ajplung.00008.2013 
(2013).
 30. Bao, H.-F. et al. ENaC activity is increased in isolated, split-open cortical collecting ducts from protein kinase Cα knockout mice. 
American Journal of Physiology - Renal Physiology 306, F309–F320, doi:10.1152/ajprenal.00519.2013 (2014).
 31. Alli, A. A. et al. Phosphatidylinositol phosphate-dependent regulation of Xenopus ENaC by MARCKS protein. Vol. 303 (2012).
 32. Wagner, C. A. et al. Mouse model of type II Bartter’s syndrome. II. Altered expression of renal sodium- and water-transporting proteins. 
Vol. 294 (2008).
 33. Venkatesan, J. K. et al. Nicotinamide adenine dinucleotide-dependent binding of the neuronal Ca2+ sensor protein GCAP2 to 
photoreceptor synaptic ribbons. J Neurosci 30, 6559–6576, doi:10.1523/JNEUROSCI.3701-09.2010 (2010).
Acknowledgements
This work was supported by the National Institutes of Health R01 DK-085097 (to R.S.H.), T32 DK07656 (B.M.W.), 
R37 DK037963 (D.C.E.). Also by the Department of Veteran Affairs MERIT Award I01BX002322-01 (R.S.H.) and 
Swiss National Foundation (F.T.). The authors would like to thank Dr. Jan Loffing for providing antibodies.
Author Contributions
B.M.W. and R.S.H. conceived manuscript. B.M.W., A.C.M., O.K. and F.T. performed experiments. B.M.W. and 
F.T. prepared figures. B.M.W. wrote manuscript; B.M.W., D.C.E. and R.S.H. edited manuscript. All authors 
approved final copy.
Additional Information
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
www.nature.com/scientificreports/
9Scientific RepoRts | 7: 4149  | DOI:10.1038/s41598-017-03510-5
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
